Endogenous prostaglandins modulate chloride secretion by prairie dog gallbladder.
In addition to concentrating bile, the gallbladder secretes chloride (Cl-) and mucus into its lumen. We recently observed that gallbladder Cl- secretion is increased in prairie dogs during the formation of cholesterol crystals, a period of altered mucosal prostaglandin synthesis. Pathologic Cl- secretion is characteristic of other epithelial disorders such as cystic fibrosis and hypercalciuric nephrolithiasis and may be important in gallstone pathogenesis. We hypothesized that concentrations of endogenous prostaglandin E2 (PGE2) found during experimental gallstone formation may mediate increased Cl- secretion by prairie dog gallbladder. Prairie dog gallbladders were harvested by cholecystectomy and mounted in Ussing chambers. Unidirectional transepithelial Cl-, Na+, and H20 fluxes were measured before and after inhibition of endogenous prostaglandin synthesis with 10 micromol/L indomethacin. Gallbladders were then exposed to increasing concentrations of PGE2 to a maximal dose of 1 micromol/L, as found in animals with gallstones. Standard electrophysiologic parameters were recorded simultaneously. Indomethacin increased mucosal resistance and stimulated gallbladder Na+ and Cl- absorption. These effects were rapidly reversed by PGE2. PGE2 promoted Cl- secretion and decreased mucosal Na+ absorption at concentrations found in the gallbladder bile of animals with gallstones. Endogenous prostaglandin metabolism modulates gallbladder Cl- secretion and may promote changes in Cl- transport associated with cholelithiasis.
Moser
A J
AJ
Department of Surgery, University of Pittsburgh School of Medicine, Pennsylvania 15213, USA.
Abedin
M Z
MZ
Morgenstern
K E
KE
Abedin
Z R
ZR
Roslyn
J J
JJ
D000818:Animals; D002470:Cell Survival; D002712:Chlorides / Q000378:metabolism*; D015232:Dinoprostone / Q000037:antagonists & inhibitors / Q000494:pharmacology / Q000502:physiology*; D004847:Epithelial Cells / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D005704:Gallbladder / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D066298:In Vitro Techniques; D007213:Indomethacin / Q000494:pharmacology; D017136:Ion Transport / Q000187:drug effects; D008297:Male; D008564:Membrane Potentials / Q000187:drug effects; D018408:Patch-Clamp Techniques; D010477:Perfusion; D012589:Sciuridae / Q000502:physiology*; D012964:Sodium / Q000378:metabolism
D002712:Chlorides; D012964:Sodium; D015232:Dinoprostone; D007213:Indomethacin